TY - JOUR T1 - Noradrenergic Modulation of Subthalamic Nucleus Activity: Behavioral and Electrophysiological Evidence in Intact and 6-Hydroxydopamine-Lesioned Rats JF - The Journal of Neuroscience JO - J. Neurosci. SP - 9595 LP - 9606 DO - 10.1523/JNEUROSCI.2583-07.2007 VL - 27 IS - 36 AU - Pauline Belujon AU - Erwan Bezard AU - Anne Taupignon AU - Bernard Bioulac AU - Abdelhamid Benazzouz Y1 - 2007/09/05 UR - http://www.jneurosci.org/content/27/36/9595.abstract N2 - The subthalamic nucleus (STN) plays a key role in the pathophysiology of Parkinson's disease. The modulation of the STN by norepinephrine, however, is unknown. The present study aims at characterizing the effects of systemic administration of noradrenergic agents on locomotor activity and on in vivo extracellularly recorded STN neuronal activity in intact and 6-hydroxydopamine (6-OHDA)-lesioned rats. Using selective agonists and antagonists of α1 and α2 adrenergic receptors (ARs), we show that STN neurons have functional α1- and α2-AR controlling STN firing with an impact on locomotor activity. We further demonstrate that those systemic effects are supported, at least in part, by a direct modulation of STN neuronal activity, using patch-clamp recordings of STN neurons in brain slices. These findings support the premise that hypokinesia is associated with an increased STN neuronal activity, and that improvements of parkinsonian motor abnormalities are associated with a decrease in STN activity. Our data challenge assumptions about the role of α1-AR and α2-AR in the regulation of STN neurons in both intact and 6-OHDA-lesioned rats and further ground the rationale for using α2-AR noradrenergic antagonists in Parkinson's disease, albeit via an unexpected mechanism. ER -